Punita Dhawan

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Ulcerative Colitis

Papillary Thyroid

Drug Administration

Top Venues

British journal of cancer

American journal of physiology. Gastrointestinal and liver physiology

Tissue barriers

This page only lists publications with an associated author ORCID identifier.

Publications

Iram Fatima, Rizwan Ahmad, Susmita Barman, Saiprasad Gowrikumar, Kristina Pravoverov, Mark Primeaux, Kurt W Fisher, Amar B Singh, Punita Dhawan
Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20. British journal of cancer 130 (6) (2024)
Iram Fatima, Rizwan Ahmad, Susmita Barman, Saiprasad Gowrikumar, Kristina Pravoverov, Mark Primeaux, Kurt W Fisher, Amar B Singh, Punita Dhawan
Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20. British journal of cancer 130 (6) (2024)
Kristina Pravoverov, Iram Fatima, Susmita Barman, Frank Jühling, Mark Primeaux, Thomas F Baumert, Amar B Singh, Punita Dhawan
IL-22 regulates MASTL expression in intestinal epithelial cells. American journal of physiology. Gastrointestinal and liver physiology 327 (2) (2024)
Iram Fatima, Rizwan Ahmad, Susmita Barman, Saiprasad Gowrikumar, Kristina Pravoverov, Mark Primeaux, Kurt W Fisher, Amar B Singh, Punita Dhawan
Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20. British journal of cancer (2024)
Kristina Pravoverov, Iram Fatima, Susmita Barman, Frank Jühling, Mark Primeaux, Thomas F Baumert, Amar B Singh, Punita Dhawan
IL-22 regulates MASTL expression in intestinal epithelial cells. American journal of physiology. Gastrointestinal and liver physiology 327 (2) (2024)
Iram Fatima, Rizwan Ahmad, Susmita Barman, Saiprasad Gowrikumar, Kristina Pravoverov, Mark Primeaux, Kurt W Fisher, Amar B Singh, Punita Dhawan
Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20. British journal of cancer 130 (6) (2024)
Iram Fatima, Rizwan Ahmad, Susmita Barman, Saiprasad Gowrikumar, Kristina Pravoverov, Mark Primeaux, Kurt W Fisher, Amar B Singh, Punita Dhawan
Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20. British journal of cancer 130 (6) (2024)
Raju Lama Tamang, Anthony F Juritsch, Rizwan Ahmad, Jeffrey D Salomon, Punita Dhawan, Amanda E Ramer-Tait, Amar B Singh
The diet-microbiota axis: a key regulator of intestinal permeability in human health and disease. Tissue barriers (2022)
Iram Fatima, Susmita Barman, JayaPrakash Uppada, Shailender S Chauhan, Sanchita Rauth, Satyanarayana Rachagani, Moorthy Palanimuthu Ponnusamy, Lynette Smith, Geoffrey Talmon, Amar B Singh, Surinder Kumar Batra, Punita Dhawan
MASTL regulates EGFR signaling to impact pancreatic cancer progression. Oncogene 40 (38) (2021)
Iram Fatima, Amar B Singh, Punita Dhawan
MASTL: A novel therapeutic target for Cancer Malignancy. Cancer medicine 9 (17) (2020)